James V. Cassella

Insider Reports History

Entity
Individual
Location
2091 Stierlin Court, Mountain View, CA
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James V. Cassella:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 400K Sep 30, 2024 Direct
Trevi Therapeutics, Inc. Chief Development Officer Nonstatutory Stock Option (right to buy) 30K Jun 13, 2024 Direct
CONCERT PHARMACEUTICALS, INC. Chief Development Officer Common Stock 0 $8.33 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Development Officer Performance Stock Units 0 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Development Officer Stock Option (Right to Buy) 0 Mar 6, 2023 Direct

Insider Reports Filed by James V. Cassella

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVI Trevi Therapeutics, Inc. Sep 30, 2024 1 $0 4 Oct 1, 2024 Chief Development Officer
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
CNCE CONCERT PHARMACEUTICALS, INC. Mar 6, 2023 10 $0 4 Mar 6, 2023 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Feb 15, 2023 1 -$31.4K 4 Feb 16, 2023 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 30, 2023 1 -$84.4K 4 Jan 31, 2023 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 6, 2023 1 -$21K 4 Jan 9, 2023 Chief Development Officer
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4/A Jul 1, 2022 Director
CNCE CONCERT PHARMACEUTICALS, INC. Feb 14, 2022 1 -$11.6K 4 Feb 16, 2022 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 5, 2022 1 -$9.23K 4 Jan 7, 2022 Chief Development Officer
CNCE CONCERT PHARMACEUTICALS, INC. Aug 16, 2021 1 -$26.5K 4 Aug 17, 2021 Chief Development Officer
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director